secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kura Oncology, Inc. (KURA)
CIK:        0001422143
Form:       8-K
Filed at:   2024-12-20T23:59:59+00:00
Accession:  0001193125-24-283109
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kura Oncology increases inducement option plan share reserve by 1.9M shares to total 2.5M
--------------------------------------------------------------------------------

- Board approved amendment to 2023 Inducement Option Plan, adding 1,900,000 shares for a new total of 2,500,000 shares reserved.
- Awards limited to nonstatutory stock options for new hires as an inducement material to employment.
- Plan approved without stockholder approval under Nasdaq Listing Rule 5635(c)(4).
- Eligible recipients are individuals not previously employees or directors; plan administered by independent directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1422143/000119312524283109/0001193125-24-283109-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1422143/000119312524283109/d801773d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-283109

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer